13-20414206-TACACACACACAC-TACACACACAC
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_015974.3(CRYL1):c.634-821_634-820delGT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.024 ( 137 hom., cov: 0)
Consequence
CRYL1
NM_015974.3 intron
NM_015974.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.523
Publications
0 publications found
Genes affected
CRYL1 (HGNC:18246): (crystallin lambda 1) The uronate cycle functions as an alternative glucose metabolic pathway, accounting for about 5% of daily glucose catabolism. The product of this gene catalyzes the dehydrogenation of L-gulonate into dehydro-L-gulonate in the uronate cycle. The enzyme requires NAD(H) as a coenzyme, and is inhibited by inorganic phosphate. A similar gene in the rabbit is thought to serve a structural role in the lens of the eye. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 13-20414206-TAC-T is Benign according to our data. Variant chr13-20414206-TAC-T is described in ClinVar as Benign. ClinVar VariationId is 1231237.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0738 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_015974.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CRYL1 | TSL:1 MANE Select | c.634-821_634-820delGT | intron | N/A | ENSP00000298248.7 | Q9Y2S2-1 | |||
| CRYL1 | TSL:1 | c.568-821_568-820delGT | intron | N/A | ENSP00000372262.1 | Q9Y2S2-2 | |||
| CRYL1 | c.595-821_595-820delGT | intron | N/A | ENSP00000557682.1 |
Frequencies
GnomAD3 genomes AF: 0.0242 AC: 3648AN: 150446Hom.: 135 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
3648
AN:
150446
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0244 AC: 3670AN: 150562Hom.: 137 Cov.: 0 AF XY: 0.0242 AC XY: 1780AN XY: 73468 show subpopulations
GnomAD4 genome
AF:
AC:
3670
AN:
150562
Hom.:
Cov.:
0
AF XY:
AC XY:
1780
AN XY:
73468
show subpopulations
African (AFR)
AF:
AC:
3114
AN:
40978
American (AMR)
AF:
AC:
239
AN:
15150
Ashkenazi Jewish (ASJ)
AF:
AC:
14
AN:
3458
East Asian (EAS)
AF:
AC:
11
AN:
5080
South Asian (SAS)
AF:
AC:
8
AN:
4736
European-Finnish (FIN)
AF:
AC:
3
AN:
10222
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
245
AN:
67666
Other (OTH)
AF:
AC:
36
AN:
2074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
156
312
467
623
779
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.